Dexmedetomidine is a selective α-2 agonist that induces sedation by reducing sympathetic outflow and provides analgesia by inhibiting substance P; it offers advantages over benzodiazepines and opioids by providing sedation and analgesia with minimal respiratory depression and greater hemodynamic stability. Here, TAC1 is linked to Respiratory insufficiency due to muscle weakness.